HOME >> MEDICINE >> NEWS
Blood pressure drugs associated with reduced risk of esophageal, pancreatic and colon cancers

LOS ANGELES Thousands of individuals currently taking angiotension converting enzyme (ACE) inhibitors, a type of medication commonly used to lower blood pressure, may be doing more than treating their hypertension. According to research presented today at Digestive Disease Week 2006 (DDW), ACE inhibitors not only effectively lower blood pressure, but they are also associated with a significant decrease in risk of developing three types of cancers: esophageal, pancreatic and colon. DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

Using a study population of nearly 500,000 U.S. veterans, researchers from the Overton Brooks VA Medical Center in Shreveport, LA, completed three case-controlled studies examining the correlation between ACE inhibitor use and esophageal, pancreatic and colon cancer incidence. The team analyzed statistics from the Veterans' Integrated Service Network (VISN 16) database, a resource tool containing information about every veteran that has received care from the South Central VA Health Care Network from October 1998 to June 2004. Among the 483,733 patients in the study, 659 had esophageal cancer, 475 had pancreatic cancer, and 6,697 had colon and rectal cancer; approximately 38 percent were taking ACE inhibitors.

While ACE inhibitors were associated with a reduction in risk for all three cancer types, it was most effective in lowering the risk of developing esophageal cancer, with a 55 percent risk reduction as compared to the controls. Results from the second study showed that ACE inhibitor use offered a 48 percent reduced risk of pancreatic cancer. And in the third study, investigators found that ACE inhibitor use was associated with a 47 percent reduced risk of colon cancer.

The studies were controlled for age, race, gender, body mass index, smoking, alcohol use, reflux, non-steroidal ant
'"/>

Contact: Aimee Frank
newsroom@gastro.org
301-941-2620
American Gastroenterological Association
23-May-2006


Page: 1 2

Related medicine news :

1. Blood inflammation plays role in Alzheimers disease
2. Blood-thinning drugs need closer monitoring
3. Blood transfusions from precancerous blood donors do not increase risk of cancer
4. Blood marker helps predict prognosis among those with abdominal infection
5. Blood transfusions raise heart patients infection and death risk -- especially women
6. Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
7. Blood cells linked to heart attacks, other inflammatory diseases
8. Blood transfusion-transmitted infections: A global perspective
9. Blood clots can be treated by injections at home
10. Blood pressure variability increases risk for stroke death
11. Canadian Blood Services scientist invents potential alternative for high-demand blood product

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... ... November 14, 2019 , ... AstraZeneca and MSD ... acceptance to file status of its application for the MEK inhibitor selumetinib, for ... type one (NF1). The FDA’s acceptance of the application is a major milestone ...
(Date:11/12/2019)... ... 2019 , ... AI for preventable harm analytics leader Jvion today announced that ... Actualizing the Potential of AI”, which provides a “tip of the spear” analysis of ... with enough clients to complete a full KLAS analysis, Jvion was featured as having ...
(Date:11/12/2019)... ... November 12, 2019 , ... The quality of study start-up ... times, extended contract negotiations and 80 percent of organizations still using spreadsheets to ... ripe for improvement. Following an overview of the challenges facing trial sponsors, this ...
(Date:11/11/2019)... ... ... Early praise for A Nurse’s Step-by-Step Guide to Publishing a Dissertation or DNP Project: ... and vital guidance for publishing dissertations or DNP projects. A Nurse’s Step-by-Step Guide to ... and will be shared with new graduates and colleagues alike.” , -Nancy White ...
(Date:11/11/2019)... (PRWEB) , ... November 11, 2019 , ... ... announced the shipment of two (2) Gruenberg Depyrogenation Sterilizers to the ... pharmaceutical sterilizers have maximum temperature ratings of 280°C with work chamber dimensions of ...
Breaking Medicine News(10 mins):
(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... ... creating a buzz with its newly opened Adult Day Care Center on Pitkin ... social activities and wellness programs focused on managing and preventing diabetes. Seniors can ...
(Date:11/6/2019)... ... 06, 2019 , ... James M. Barthel, CEO of MT2 Firing Range Services ... their range lead into profit by giving the range owner/manager the highest value for ... the absolute highest value for their lead. No one reclaims more lead or pays ...
(Date:11/6/2019)... ... 2019 , ... Enara Health , a technology-powered clinical ... behaviors that are associated with higher weight loss in individuals enrolled in a ... study, “Mobile Engagement Behaviors Associated With Sustained 15% Weight Loss,” provides real-world evidence ...
Breaking Medicine Technology:
Cached News: